Skip to main content
Log in

Berberine Attenuates Cigarette Smoke-Induced Acute Lung Inflammation

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Berberine (Ber), the major constituent of Coptidis Rhizoma, possesses anti-inflammatory properties. In this study, we investigated the effects of Ber on cigarette smoke (CS)-mediated acute lung inflammation. C57BL/6 mice (6–8 weeks) were exposed to CS to induce acute lung injury. Ber was used to pretreat CS-exposed mice (50 mg/kg, intragastrically). Lung tissues were collected for histological examination, myeloperoxidase (MPO) activity assay, Western blot analysis, and electrophoretic mobility shift assay. Bronchoalveolar lavage fluid (BALF) was measured for cell counts and cytokine analysis. Histological examination showed that CS exposure caused infiltration of inflammatory cells into alveolar spaces and interstitial edema. Pretreatment with Ber significantly attenuated CS-induced lung inflammation. The numbers of total cells, macrophages, and neutrophils in BALF were decreased by 43, 40, and 53 %, respectively, by Ber pretreatment in CS-exposed mice, accompanied by decreased MPO activity, a marker of neutrophil accumulation. Ber pretreatment also profoundly diminished CS-induced secretions of macrophage inflammatory protein 2, tumor necrosis factor alpha, interleukin-6, and monocyte chemotactic protein-1 in BALF, along with less nuclear translocation of the pro-inflammatory transcription factor nuclear factor-kappa B (NF-κB) p65 subunit and lower NF-κB DNA-binding activity (P < 0.01). Thus, our results indicated that Ber ameliorates CS-induced acute lung injury through its anti-inflammatory activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Rabe, K.F., B. Beghé, F. Luppi, and L.M. Fabbri. 2007. Update in chronic obstructive pulmonary disease 2006. American Journal of Respiratory and Critical Care Medicine 175: 1222–1232.

    Article  PubMed  CAS  Google Scholar 

  2. Rabe, K.F., S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, J. Zielinski, and Global Initiative for Chronic Obstructive Lung Disease. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 176: 532–555.

    Article  PubMed  Google Scholar 

  3. Stampfli, M.R., and G.P. Anderson. 2009. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nature Reviews Immunology 9: 377–384.

    Article  PubMed  Google Scholar 

  4. Hogg, J.C., F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, R.M. Cherniack, R.M. Rogers, F.C. Sciurba, H.O. Coxson, and P.D. Paré. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. The New England Journal of Medicine 350: 2645–2653.

    Article  PubMed  CAS  Google Scholar 

  5. Profita, M., A. Sala, A. Bonanno, L. Riccobono, M. Ferraro, S. La Grutta, G.D. Albano, A.M. Montalbano, and M. Gjomarkaj. 2010. Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products. American Journal of Physiology. Lung Cellular and Molecular Physiology 298: L261–L269.

    Article  PubMed  CAS  Google Scholar 

  6. Thatcher, T.H., S.B. Maggirwar, C.J. Baglole, H.F. Lakatos, T.A. Gasiewicz, R.P. Phipps, and P.J. Sime. 2007. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. American Journal of Pathology 170: 855–864.

    Article  PubMed  CAS  Google Scholar 

  7. Wright, J.G., and J.W. Christman. 2003. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. American Journal of Respiratory Medicine 2: 211–219.

    Article  PubMed  CAS  Google Scholar 

  8. Rajendrasozhan, S., J.W. Hwang, H. Yao, N. Kishore, and I. Rahman. 2010. Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke. Pulmonary Pharmacology & Therapeutics 23: 172–181.

    Article  CAS  Google Scholar 

  9. Park, J.J., S.M. Seo, E.J. Kim, Y.J. Lee, Y.G. Ko, J. Ha, and M. Lee. 2012. Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling. Biochemical and Biophysical Research Communications 426: 461–467.

    Article  PubMed  CAS  Google Scholar 

  10. Iizuka, N., K. Miyamoto, K. Okita, A. Tangoku, H. Hayashi, S. Yosino, T. Abe, T. Morioka, S. Hazama, and M. Oka. 2000. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Letters 148: 19–25.

    Article  PubMed  CAS  Google Scholar 

  11. Marinova, E.K., D.B. Nikolova, D.N. Popova, G.B. Gallacher, and N.D. Ivanovska. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology 48: 9–16.

    Article  PubMed  CAS  Google Scholar 

  12. Liu, Y., H. Yu, C. Zhang, Y. Cheng, L. Hu, X. Meng, and Y. Zhao. 2008. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. European Journal of Cancer 44: 2425–2432.

    Article  PubMed  CAS  Google Scholar 

  13. Zhang, H.Q., H.D. Wang, D.X. Lu, R.B. Qi, Y.P. Wang, Y.X. Yan, and Y.M. Fu. 2008. Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. Shock 29: 617–622.

    PubMed  Google Scholar 

  14. Vlahos, R., S. Bozinovski, J.E. Jones, J. Powell, J. Gras, A. Lilja, M.J. Hansen, R.C. Gualano, L. Irving, and G.P. Anderson. 2006. Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L931–L945.

    Article  PubMed  CAS  Google Scholar 

  15. Yao, H., I. Edirisinghe, S.R. Yang, S. Rajendrasozhan, A. Kode, S. Caito, D. Adenuga, and I. Rahman. 2008. Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice. American Journal of Pathology 172: 1222–1237.

    Article  PubMed  CAS  Google Scholar 

  16. Tian, J., X. Lin, R. Guan, and J.G. Xu. 2004. The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesthesia and Analgesia 98: 768–774.

    Article  PubMed  CAS  Google Scholar 

  17. Li, F., H.D. Wang, D.X. Lu, Y.P. Wang, R.B. Qi, Y.M. Fu, and C.J. Li. 2006. Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice. Acta Pharmacologica Sinica 27: 1199–1205.

    Article  PubMed  Google Scholar 

  18. Anto, R.J., A. Mukhopadhyay, S. Shishodia, C.G. Gairola, and B.B. Aggarwal. 2002. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 23: 1511–1518.

    Article  PubMed  CAS  Google Scholar 

  19. Shishodia, S., P. Potdar, C.G. Gairola, and B.B. Aggarwal. 2003. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24: 1269–1279.

    Article  PubMed  CAS  Google Scholar 

  20. Milner, D. 2004. The physiological effects of smoking on the respiratory system. Nursing Times 100: 56–59.

    PubMed  Google Scholar 

  21. Blake, D.J., A. Singh, P. Kombairaju, D. Malhotra, T.J. Mariani, R.M. Tuder, E. Gabrielson, and S. Biswal. 2010. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. American Journal of Respiratory Cell and Molecular Biology 42: 524–536.

    Article  PubMed  CAS  Google Scholar 

  22. Podowski, M., C. Calvi, S. Metzger, K. Misono, H. Poonyagariyagorn, A. Lopez-Mercado, T. Ku, T. Lauer, S. McGrath-Morrow, A. Berger, C. Cheadle, R. Tuder, H.C. Dietz, W. Mitzner, R. Wise, and E. Neptune. 2012. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. The Journal of Clinical Investigation 122: 229–240.

    Article  PubMed  CAS  Google Scholar 

  23. Iribarren, C., D.R. Jacobs Jr., S. Sidney, M.D. Gross, and M.D. Eisner. 2000. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest 117: 163–68.

    Article  PubMed  CAS  Google Scholar 

  24. Rajendrasozhan, S., S.R. Yang, I. Edirisinghe, H. Yao, D. Adenuga, and I. Rahman. 2008. Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxidants & Redox Signaling 10: 799–811.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qi Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, K., Liu, S., Shen, Y. et al. Berberine Attenuates Cigarette Smoke-Induced Acute Lung Inflammation. Inflammation 36, 1079–1086 (2013). https://doi.org/10.1007/s10753-013-9640-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-013-9640-0

KEY WORDS

Navigation